Pharmacological investigations on etoperidone, a new psychotropic agent.
D000700:Analgesics; D000818:Animals; D000927:Anticonvulsants; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002389:Catatonia / Q000139:chemically induced; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors; D004285:Dogs; D004347:Drug Interactions; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D010095:Oxotremorine / Q000037:antagonists & inhibitors; D010879:Piperazines / Q000494:pharmacology*; D011619:Psychotropic Drugs / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects; D014196:Trazodone / Q000031:analogs & derivatives / Q000494:pharmacology*
D000700:Analgesics; D000927:Anticonvulsants; D010879:Piperazines; D011619:Psychotropic Drugs; D010095:Oxotremorine; D012110:Reserpine; D003913:Dextroamphetamine; D014196:Trazodone